Akari Therapeutics Plc
AKTX · Pharmaceutical Preparations · 91.57B shares · +96%/yr ↑ shares · EDGAR filings ↗
Reference price $0.90 · est. market cap ~$82.4B — last insider purchase, 2025-08-25 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
F36Clinical/early-stage biotech — near-insolvent.
Strengths
- Liquidity — current ratio 0.4 (9th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- No interest coverageInterest coverage -172.75 (cannot cover interest)
- Weak liquidityCurrent ratio 0.44 (<1)
- Material weakness● We have identified material weaknesses in our internal control over financial reporting
- Chronic dilutionShare count +96%/yr over 2y (dilution)
Key metrics
Return on equity
-61.1%
Return on assets
-36.1%
Interest coverage
-172.8×
Current ratio
0.4×
Tangible book value
$20M
Cash & investments
$0
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-24 | Farag Kameel D. | Grant | 1.4K | $9.32 |
| 2026-06-24 | Farag Kameel D. | Grant | 1.2K | $10.02 |
| 2026-06-24 | Farag Kameel D. | Grant | 1.6K | $8.28 |
| 2026-06-24 | Farag Kameel D. | Grant | 2.5K | $5.12 |
| 2026-06-24 | Farag Kameel D. | Grant | 3.7K | $3.49 |
| 2026-06-24 | Farag Kameel D. | Grant | 7.4K | $3.74 |
| 2026-06-24 | Farag Kameel D. | Grant | 1.0K | $13.00 |
| 2025-11-01 | Farag Kameel D. | Grant | 27K | $0.75 |
| 2025-11-01 | Farag Kameel D. | Grant | 32K | $0.75 |
| 2025-10-22 | Farag Kameel D. | Grant | 6.3K | $0.74 |
| 2025-08-25 | Gaslightwala Abizer | Buy | 3.0K | $0.90 |
| 2025-08-22 | Gaslightwala Abizer | Buy | 8.0K | $0.93 |
| 2025-08-21 | Gaslightwala Abizer | Buy | 10K | $0.94 |
| 2025-06-24 | Gaslightwala Abizer | Buy | 5.2K | $1.16 |
| 2025-06-23 | Gaslightwala Abizer | Buy | 943 | $1.15 |
| 2025-06-20 | Gaslightwala Abizer | Buy | 10K | $1.20 |
| 2025-06-17 | Gaslightwala Abizer | Buy | 15K | $1.20 |
| 2025-06-13 | Gaslightwala Abizer | Grant | 25K | $1.19 |
| 2025-06-12 | Gaslightwala Abizer | Grant | 20K | $1.23 |
| 2025-06-10 | Gaslightwala Abizer | Grant | 20K | $1.27 |
| 2025-03-06 | Prudo-Chlebosz Raymond | Grant | 446K | $1.12 |
| 2025-03-06 | Patel Samir Rashmikant | Grant | 406K | $1.12 |
| 2025-03-06 | Neal James R | Grant | 4.5K | $1.12 |
| 2025-03-06 | Bazemore Robert B | Grant | 45K | $1.12 |
| 2025-03-06 | Gaslightwala Abizer | Grant | 134K | $1.12 |
| 2025-03-06 | Patel Sandip I | Grant | 45K | $1.12 |
| 2025-03-06 | Huh Hoyoung | Grant | 893K | $1.12 |
| 2025-01-10 | Gaslightwala Abizer | Grant | 12K | $1.22 |
| 2025-01-10 | Gaslightwala Abizer | Grant | 11K | $1.22 |
| 2025-01-10 | Hombeck Torsten | Grant | 200 | $1.22 |
| 2025-01-09 | Neal James R | Grant | 8.0M | $0.00 |
| 2025-01-03 | Gaslightwala Abizer | Grant | 1.7M | $0.00 |
| 2025-01-03 | Patel Samir Rashmikant | Grant | 208K | $0.00 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-26 | Material agreementExhibits | filing ↗ |
| 2026-05-22 | Material agreement3.02Exhibits | filing ↗ |
| 2026-03-17 | 3.03Reg FDExhibits | filing ↗ |
| 2026-03-02 | Shareholder vote | filing ↗ |
| 2025-12-17 | Material agreement1.023.02Reg FDExhibits | filing ↗ |
| 2025-12-16 | Shareholder voteExhibits | filing ↗ |
| 2025-12-08 | Reg FDExhibits | filing ↗ |
| 2025-11-26 | Delisting notice | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-26 | 2026-06-23 | 0001493152-26-030341 ↗ |
| 8-K | 2026-05-22 | 2026-05-20 | 0001493152-26-025037 ↗ |
| 10-Q | 2026-05-19 | 2026-03-31 | 0001493152-26-024446 ↗ |
| 10-K | 2026-03-30 | 2025-12-31 | 0001493152-26-013664 ↗ |
| 8-K | 2026-03-17 | 2026-03-17 | 0001493152-26-010602 ↗ |
| 8-K | 2026-03-02 | 2026-03-02 | 0001493152-26-008570 ↗ |
| 8-K | 2025-12-17 | 2025-12-16 | 0001493152-25-028075 ↗ |
| 8-K | 2025-12-16 | 2025-12-15 | 0001493152-25-027969 ↗ |
| 8-K | 2025-12-08 | 2025-12-08 | 0001493152-25-026533 ↗ |
| 8-K | 2025-11-26 | 2025-11-24 | 0001493152-25-025177 ↗ |
| 10-Q | 2025-11-13 | 2025-09-30 | 0001493152-25-022390 ↗ |
| 8-K | 2025-10-23 | 2025-10-22 | 0001493152-25-019112 ↗ |